Omnicell schedules Q3 2026 results release for Oct. 29
Omnicell will release its third-quarter 2026 financial results before market open on October 29, 2026, with a conference call at 8:30 a.m. ET.
FORT WORTH, Texas--()--October 08, 2026- Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the third quarter 2026, before market open on Thursday, October 29, 2026. m. ET that same day.
S. or (585) 542-9983 in international locations. The Conference ID is 574173299. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell's website at About Omnicell Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care.
As an intelligent medication management technology company, Omnicell empowers autonomous medication management by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities worldwide. com. OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.
com CONTACT: Investor Relations Contact David Unger VP, Investor Relations Omnicell, Inc. com (END) Dow Jones Newswires October 08, 2026 16:03 ET (20:03 GMT) The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.